Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Nicholson

Showing results (191-200 of 243) with videos related to

Pageof 25
Sort By:
Clinical and Experimental Immunology|April 5, 2012
Tumour necrosis factor-mediated macrophage activation in the target organ is critical for clinical manifestation of uveitisT K Khera, D A Copland, J Boldison, et al.
Clinical and Experimental Immunology|December 17, 2009
Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitisD A Copland, K Hussain, S Baalasubramanian, et al.
Current Drug Targets|November 23, 2012
A key role for connexin hemichannels in spreading ischemic brain injuryJoanne O Davidson, Colin R Green, Laura Bennet, et al.
Journal of Cellular and Molecular Medicine|October 20, 2020
Treatment with interleukin-33 is non-toxic and protects retinal pigment epithelium in an ageing model of outer retinal degenerationAlison J Clare, David A Copland, Lindsay B Nicholson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 18, 2014
Tissue-resident exhausted effector memory CD8+ T cells accumulate in the retina during chronic experimental autoimmune uveoretinitisJoanne Boldison, Colin J Chu, David A Copland, et al.
Transplantation Proceedings|June 1, 1993
Individual and species differences in the in vitro sensitivity to brequinar sodiumG Eiras-Hreha, D V Cramer, E Cajulis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2007
CD4+CD25(int) T cells in inflammatory diseases refractory to treatment with glucocorticoidsRichard W J Lee, Thomas J Creed, Lauren P Schewitz, et al.
Alimentary Pharmacology & Therapeutics|November 25, 2005
Review article: Population screening for colorectal cancerF B Nicholson, J L Barro, W Atkin, et al.
The Medical Journal of Australia|December 24, 1977
Retrieval of the critically ill in South Australia: a coordinated approachJ E Gilligan, D McCleave, B Nicholson, et al.
Neuroscience|June 16, 2009
Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's diseaseM J Dowie, H B Bradshaw, M L Howard, et al.
Pageof 25

Showing results (191-200 of 243) with videos related to

Sort By:
Pageof 25
Clinical and Experimental Immunology|April 5, 2012
Tumour necrosis factor-mediated macrophage activation in the target organ is critical for clinical manifestation of uveitisT K Khera, D A Copland, J Boldison, et al.
Clinical and Experimental Immunology|December 17, 2009
Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitisD A Copland, K Hussain, S Baalasubramanian, et al.
Current Drug Targets|November 23, 2012
A key role for connexin hemichannels in spreading ischemic brain injuryJoanne O Davidson, Colin R Green, Laura Bennet, et al.
Journal of Cellular and Molecular Medicine|October 20, 2020
Treatment with interleukin-33 is non-toxic and protects retinal pigment epithelium in an ageing model of outer retinal degenerationAlison J Clare, David A Copland, Lindsay B Nicholson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 18, 2014
Tissue-resident exhausted effector memory CD8+ T cells accumulate in the retina during chronic experimental autoimmune uveoretinitisJoanne Boldison, Colin J Chu, David A Copland, et al.
Transplantation Proceedings|June 1, 1993
Individual and species differences in the in vitro sensitivity to brequinar sodiumG Eiras-Hreha, D V Cramer, E Cajulis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2007
CD4+CD25(int) T cells in inflammatory diseases refractory to treatment with glucocorticoidsRichard W J Lee, Thomas J Creed, Lauren P Schewitz, et al.
Alimentary Pharmacology & Therapeutics|November 25, 2005
Review article: Population screening for colorectal cancerF B Nicholson, J L Barro, W Atkin, et al.
The Medical Journal of Australia|December 24, 1977
Retrieval of the critically ill in South Australia: a coordinated approachJ E Gilligan, D McCleave, B Nicholson, et al.
Neuroscience|June 16, 2009
Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's diseaseM J Dowie, H B Bradshaw, M L Howard, et al.
Pageof 25